At a glance
ClinicalIndex Comparison RecordN/ACompleted· 11 enrolled
Drug / intervention
lorazepam +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Absorption of "ABH Gel" (Ativan®, Lorazepam; Benadryl®, Diphenhydramine; and Haldol®, Haloperidol Gel) From the Skin of Normal Volunteers
In Brief
A clinical study evaluating lorazepam, diphenhydramine hydrochloride, and 3 other interventions for Healthy. Completed, enrolled 11 participants across 1 site.
Detailed Summary
RATIONALE: Lorazepam, diphenhydramine hydrochloride, and haloperidol gel, when absorbed into the skin, may be an effective treatment for nausea and vomiting.PURPOSE: This clinical trial studies lorazepam, diphenhydramine hydrochloride, and haloperidol gel in healthy volunteers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI), American Cancer Society, Inc.
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2010
Enrollment StartNov 2010
Primary CompletionApr 2011
Study CompletionMay 2011
TodayJul 2026
First PostedSep 17, 2010
Enrollment StartNov 15, 2010
Primary CompletionApr 18, 2011
Study CompletionMay 17, 2011
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 15.8 years ago
Interventions
lorazepamdrug
Given topically
diphenhydramine hydrochloridedrug
Given topically
haloperidoldrug
Given topically
questionnaire administrationother
Ancillary studies
laboratory biomarker analysisother
Correlative studies